Major innovator brands see no price reductions despite cuts of up to 93 per cent for some cancer medicines; patient groups say PAP exclusions and data gaps have diluted relief
The Supreme Court questioned steep hospital mark-ups on cancer medicines and medical consumables, criticised the Centre's pricing framework and reserved its verdict on a plea seeking tighter controls
Blume Ventures and South Park Commons led the funding round as Cent plans to expand its AI-powered medical imaging, diagnostics and preventive healthcare services in India
Takotsubo cardiomyopathy can temporarily weaken the heart after intense emotional or physical stress, mimicking a heart attack
AIMED calls for stricter inspections, traceable disposal records and clear liability rules to protect patient safety
France has reported the first documented human infection with the Shamonda virus. There is no evidence of human-to-human transmission, but investigations into the case continue
The Bhubaneswar-based healthtech firm raised Rs 69 crore in equity and over Rs 30 crore in debt to expand its rural clinic network and strengthen AI-powered healthcare services
New prices set to come into effect from November 9, 2026; state drug controllers to monitor implementation
A study of 13,825 people found that 53 per cent had experienced mental health concerns for over a year before reaching the provider, highlighting barriers to timely care
The move could bring down the MRPs of cancer medicines by up to 70 per cent and save consumers an estimated ₹2,500 crore annually
Doctors have urged research into potential links between PM2.5, ground-level ozone and gastrointestinal cancers, cautioning that international studies show associations but don't establish causations
Protein-rich fermented foods may support gut health, metabolism and inflammation control, but evidence that they directly improve muscle mass or strength remains limited
A review of nearly three decades of research across 76 countries found women score higher on average, particularly in recognising and managing others' emotions
Both options can lower premiums, but they increase out-of-pocket expenses during claims. Understand how they work before choosing a health insurance policy
Under the current rules, pharmaceutical manufacturers cannot advertise drugs covered under Schedules H, H1 and X without prior approval from the Central Government
Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups
The Supreme Court asks the Centre and amicus curiae to propose a permanent corpus for SMA patients, funded through CSR contributions and government grants to ensure treatment support
More than 70 per cent of new cases are outside known contacts, and 60 per cent of deaths occur outside treatment centres, raising concerns over gaps in the response
Insurance cover and hospitals could drive the next phase of expansion. But evidence-backed treatment will be key
The combined Maharashtra business is expected to generate around ₹500 crore in revenue this year, with plans to establish a presence in every district headquarters